Navigation Links
Thomas Jefferson University Hospital adopts new imaging agent to improve detection of bladder cancer
Date:10/20/2011

PHILADELPHIAThomas Jefferson University Hospital (embed link into full hospital name "www.jeffersonhospital.org) is one of a select number of medical centers nationwideand currently the only one in the Northeastoffering a newly approved optical imaging agent for the detection of papillary cancer of the bladder in patients with known or suspected bladder cancer.

The availability of imaging agent known as Cysview signals the arrival of an innovative diagnostic technology for patients who have or may have bladder cancer, and underscores Jefferson's reputation as a leading comprehensive medical facility in the Delaware Valley.

The imaging agent is used to detect bladder cancer in individuals suspected or known to have lesion(s) in the bladder, based on a prior cystoscopy (the examination of the bladder and urethra using a cystoscope, a thin, tube-like instrument with a light and a lens for viewing). It is used with a white light setting to illuminate the bladder during a routine cystoscopy, and a blue light setting to induce and view fluorescence, thereby enabling physicians to detect lesions in the bladder.

More than 70,000 people in the United States were diagnosed with cancer of the bladder in 2009, and an estimated 14,000 Americans died from the disease last year, according to the National Cancer Institute

Bladder cancer is the fourth most common type of cancer in men, and the eighth most common in women. Smoking is the most likely cause of bladder cancer. The most common initial sign of the disease is red-colored urine, which calls for urine cytology (tests performed on cells in urine to detect disease) and cystoscopy.

"Bladder cancer is difficult to detect. A missed diagnosis can result in delayed or incomplete treatment, which may lead to serious complications and a lower chance of survival for patients with potentially aggressive tumors," said Leonard Gomella, M.D., F.A.C.S., the Bernard W. Godwin, Jr. Professor of Prostate Cancer, associate director for Clinical Affairs at the Kimmel Cancer Center at Jefferson, and Chair of the Department of Urology at Thomas Jefferson University Hospital. "Cysview represents an important advance in diagnostic technology, enabling more accurate diagnosis of bladder tumors compared to the standard technique.

"Patients with known or suspected bladder cancer can now come to Jefferson to undergo diagnostic procedures administered by physicians who have been specially trained in the use of this innovative technology."

The standard diagnostic procedure for bladder cancer combines urine cytology and white light cystoscopy. Although cytology provides specificity and sensitivity in detecting high-grade (highly abnormal) lesions, it provides no information on the location and extent of the disease. If the cells test positive for cancer, the next step is direct visual inspection of the urothelium and mucosa (the inside of the bladder) with white light cystoscopy to localize the tumors. Physicians perform transurethral resection (TUR), a form of cystoscopy-guided biopsy, of suspicious areas of the bladder, and then test the tissue samples to determine if they are malignant.

"We are dedicated to finding new ways to improve the lives of patients living with serious diseases such as cancer, and Cysview is the latest example," said Dr. Gomella. "By facilitating early diagnosis of bladder cancer, this innovative imaging agent can enable appropriate, timely treatment that may improve patients' chances of survival."


'/>"/>

Contact: Steve Graff
stephen.graff@jefferson.edu
215-955-5291
Thomas Jefferson University
Source:Eurekalert  

Related medicine news :

1. Thomas Jefferson University and hospitals tasked to find new radiation drugs
2. Thomas Kipps receives ACGT Investigator Award
3. Thomas Jefferson University professor elected AAAS Fellow
4. Gala honors County Supervisor Mark Ridley-Thomas and businesswoman Anne-Merelie Murrell
5. Nationally Renowned Knee Specialist Dr. Thomas Meade Joins Coordinated Health
6. Thomas E. Heftler Migraine Research Award
7. Life Coach and Author Thomas Finn's Highly Anticipated Book, 'A Better Tomorrow- Affirmations and Visualizations the Keys to Success,' Debuts June 15
8. Thomas E. Mower Makes Generous Donations To Primary Children's Medical Center
9. Thomas E. Mower And Karl Malone Instrumental To Success Of Sportsmen For Fish And Wildlife Organization
10. Leading Orthopaedic Surgeon and Regenerative Medical Authority Dr. Thomas A. Einhorn Advances Adult Stem Cell Therapy To Eliminate Hip Replacement Surgery
11. Thomas J. Kent Jr. FDP Capital, LLC Chairman and Former NFL Player Jack Brewer Join Forces
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Thomas Jefferson University Hospital adopts new imaging agent to improve detection of bladder cancer
(Date:12/6/2016)... ... ... The Touchpoint Solution’s new neuroscience wearable, Buzzies, generated over $100K in sales online ... $25,000 on Kickstarter to bring to the market what people are calling ... inventor, says she feels like she stumbled upon a miracle that she wants other ...
(Date:12/6/2016)... ... ... Of the variety of ingredients in the food supply, few spark more ... beliefs that hot dogs include “everything but the oink,” today’s wieners are made from ... meat and poultry in a hot dog recipe can add flavor, keep hot dogs ...
(Date:12/6/2016)... ... December 06, 2016 , ... Public middle and high schools ... apply for a 2016/2017 California Casualty Thomas R. Brown Athletics Grant. The application ... receive up to $3,000. , The grant is named after California Casualty ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... charity, is thrilled to formally announce its Not a Moment to Lose fundraising ... Lose will rally supporters dedicated to declaring victory over cancer. The campaign aims ...
(Date:12/6/2016)... ... December 06, 2016 , ... METTLER TOLEDO has ... knowledge resources, including white papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, ... more than 9,000 documents, webinars and videos available online, visit the METTLER ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016  Nearly 30 million people in ... the epidemic of diabetes. 1 However, nearly 40% ... glucose levels (hyperglycemia) and significant glucose variability. 2 These ... including cardiovascular events. If left untreated, hyperglycemia can lead ... disease or blindness. 3 As part ...
(Date:12/6/2016)... 6, 2016   Sienna Biopharmaceuticals, Inc. ... and aesthetics company, today announced it has ... pharmaceutical company focused on developing first-in-class topical ... psoriasis, atopic dermatitis and pruritus (itch). Under ... make an undisclosed upfront payment in cash ...
(Date:12/6/2016)... 6, 2016  Viking Therapeutics, Inc. ("Viking") (NASDAQ: ... focused on the development of novel therapies for ... U.S. Food and Drug Administration (FDA) has granted ... of X-linked adrenoleukodystrophy (X-ALD).  VK0214 is a novel, ... selectively regulates the expression of genes believed to ...
Breaking Medicine Technology: